Manuel Avina

Manuel Aviña is an expert in value-based initiatives and public health, and advises clients on diverse healthcare policy issues affecting their priorities.

Prior to joining Avalere, Manuel was a Congressional Hispanic Caucus Institute Preventative Health Fellow in the U.S. House of Representatives, where he managed various healthcare bills focused on drug transparency, healthcare coverage, and nursing staffing ratios. Additionally, as a fellow in the Federal Relations Department at the American Hospital Association (AHA), he developed a value proposition and communication materials for a community violence project with AHA and UnidosUS. Additionally, in that role, he published a white paper and hosted a congressional panel on the role that hospitals’ community benefits play in addressing housing insufficiencies.

Manuel holds a MPH from the University of Michigan and a BA in urban studies and planning from the University of California, San Diego.

Authored Content

New Avalere analysis finds higher premiums for the enhanced standalone drug plans participating in the model.

As currently written, a proposed rule on rebate reform from January 2019 may impose financial and operational challenges for pharmacies related to cash flow and new technology requirements.

Avalere assessed the impacts of select policies to expand low-income subsidy (LIS) eligibility under Medicare Part D

Recent regulatory changes have eased restrictions for providers delivering care across state lines during the COVID-19 public health emergency. However, state and federal cooperation on extended licensure expansion would help address long-term provider access issues.

As COVID-19 continues to stress the US healthcare system, pharmacists and retail pharmacies may help respond to the pandemic.

An Avalere analysis finds that Medicare Part D plans allow $0 cost-sharing for select vaccines just 4% of the time, likely affecting immunization uptake.

New flexibilities for telehealth services in fee-for-service (FFS) Medicare are designed to support ongoing COVID-19 response efforts.

Employer Group Waiver Plans (EGWPs) have lower out-of-pocket (OOP) costs for multiple sclerosis (MS) drugs than beneficiaries enrolled in other types of Part D plans.

Remote patient monitoring (RPM) provides an opportunity to diagnose and treat patients facing neurological diseases. Given that multiple sclerosis (MS), Parkinson’s disease, and epilepsy require intervention from specialized care teams, effective management of these chronic neurological conditions can be supported through RPM to improve patient outcomes. Although RPM has been shown to be a complement and in some cases an alternative to office-based care, reimbursement and coverage barriers remain.

On November 13, Avalere policy experts published a piece in the Health Affairs blog about considerations for developing and harmonizing HIV prevention recommendations to drive the goal of eliminating HIV.

States are increasingly seeking to improve access and health outcomes for their underserved, rural, or homebound populations, and many are turning to telehealth as a solution.